CDK12/13 dual inhibitors are potential therapeutics for acute myeloid leukemia

Br J Haematol. 2023 Jul;202(1):195-198. doi: 10.1111/bjh.18843. Epub 2023 May 14.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclin-Dependent Kinases
  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy

Substances

  • Cyclin-Dependent Kinases
  • CDK12 protein, human